Mergers & Acquisitions ·
Curaleaf Holdings issued a press release urging Aurora Cannabis shareholders to accept its tender offer, which…
CURLDCuraleaf Holdings, Inc.
Curaleaf Holdings issued a press release urging Aurora Cannabis shareholders to accept its tender offer, which provides a 45% premium over the August 10, 2026 volume-weighted average price. The consideration consists of 0.3463 Curaleaf shares and $0.75 cash per Aurora share, implying an offer price of $4.00. The combined entity would generate approximately US$1.5 billion in trailing twelve-month revenue and nearly US$350 million in adjusted EBITDA, with at least US$40 million in expected annual cost synergies. Curaleaf Chairman and CEO Boris Jordan will host a shareholder Q&A on September 17, 2026. The tender offer deadline is December 1, 2026. Curaleaf Holdings operates as a leading international provider of consumer and medical cannabis products.